Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...

A false claim is circulating online that the European Medicines Agency (EMA) has acknowledged that mRNA vaccines have not been formally approved and that millions have therefore been vaccinated ...

The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively ...

A personalized mRNA vaccine for pancreatic cancer has shown early promise in a small phase 1 trial ... [+] of 16 people. A mRNA-based cancer vaccine has shown impressive results in a small trial ...

As it did during the COVID-19 pandemic, mRNA technology offers an efficient way forward in developing products for diseases ...

A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...

As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small ...

Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...

The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...